4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-24-004564
Chief Executive Officer sold 39,384 shares at an average $0.70 ($27,594)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2024-01-16 | Sale | −9,304 | $0.79 | $7,350 | 14,104 | D |
| Rawcliffe Adrian Chief Executive Officer | 2024-01-17 | Sale | −30,080 | $0.67 | $20,244 | 44,848 | D |
| Open-market sales · 39,384 sh · avg $0.70 · $27,594 | |||||||
Loading xslF345X05/tm243270-16_4seq1.xml…